Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322737 · ClinicalTrials.gov registry record · NA
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
A NA study of Gastric Disease and Colon Disease, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT01322737 is a NA study of Gastric Disease and Colon Disease that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01322737, a NA study of Gastric Disease and Colon Disease, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility trial will evaluate the ability of the SuMO Tissue Access and Resection System (Apollo Endosurgery, Austin, Texas). The SuMO System utilizes balloons to create a submucosal pocket and electrosurgical cutting device to resect the mucosa. The SuMO elevates the tissue from the underlying muscularis using a balloon to distend the submucosa, similar to what is currently performed with injectable saline in a standard EMR. After dissection of the lesion, a separate cutting device will be utilized to resect the tissue by cutting around the border of the targeted tissue. If needed, a standard loop snare will be used to complete the mucosal resection.
Conditions Studied
Interventions
- PROCEDURE Tissue Access and Resection System
Study Locations (1)
Ohio
- University Hospitals Case Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01322737
The ClinicalTrials.gov registry entry for NCT01322737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastric Disease appearing as the primary indexed condition, and to 1 intervention - of which Tissue Access and Resection System is the first listed.
NCT01322737 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01322737 about?
NCT01322737 is a clinical study titled "Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System". This feasibility trial will evaluate the ability of the SuMO Tissue Access and Resection System (Apollo Endosurgery, Austin, Texas). The SuMO System utilizes balloons to create a submucosal pocket and electrosurgical cutting device to resect the mucosa. The SuMO elevates the tissue from the underlyi...
What is the current status of trial NCT01322737?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2011-01. Estimated completion is 2011-06.
What conditions does trial NCT01322737 study?
This clinical trial studies the following conditions: Gastric Disease, Colon Disease.
What interventions are being tested in trial NCT01322737?
The interventions under investigation include: Tissue Access and Resection System (PROCEDURE).
Who is sponsoring clinical trial NCT01322737?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01322737 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.